HMD HeraMED Limited
Healthcare · Medical Devices
· website
$0.04
52wk 0.03 – 0.06
Overall
34.9
Value
45.5
Growth
4.0
Health
69.2
Quality
0.0
Momentum
51.4
Dividend
—
Price
About HeraMED Limited
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.
Price analytics
Returns
| 1 day | -2.3% |
| 1 week | -6.7% |
| 1 month | 16.7% |
| 3 months | 0.0% |
| 6 months | -14.3% |
| 1 year | 7.7% |
| 3 years | -30.8% |
Risk
| Volatility (1y ann.) | 74.2% |
| Beta vs ASX 200 | 0.49 |
| Sharpe (1y) | 0.41 |
| VaR 95% (1-day) | -6.8% |
| Max drawdown (1y) | -34.0% |
| Off 1-year high | -16.0% |
Technicals
| RSI(14) | 70 |
| vs 50DMA | 9.9% |
| vs 200DMA | 4.4% |
| Trend | Death cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
45.5
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
0
Price / Sales
0
Growth
4.0
Revenue growth (1y)
0
Revenue CAGR (3y)
8
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health
69.2
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow)
0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
51.4
6-month return vs ASX 200
11
Price vs 200-day average
65
Price vs 50-day average
99
Position in 52-week range
48
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$48.66M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
0.05
EV / EBITDA
-12.44
Price / Book
21.00
ROE
-223.7%
Operating margin
-4,102.1%
Net margin
0.0%
Total cash
$2.93M
Total debt
$0
Current ratio
9.09
Debt / Equity
0.12
Free cash flow
$-1.73M
Avg volume
768,923
Latest annual results
(FY ending 31 Dec 2025)
- Revenue$293.38K
- Gross profit$293.38K
- Operating income-$3.60M
- Net income-$4.13M
- Diluted EPS-0.00
- Free cash flow-$3.66M
- Net debt-$1.09M